Philips Healthcare has signed two settlements with the US Department of Justice, putting to rest two separate False Claims Act allegations at a cost of just over $28m.
The larger settlement, which was announced on 1 September, involves alleged kickbacks paid by Philips subsidiary Philips Respironics, formerly known as Respironics, Inc.. The company reportedly gave physician prescribing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?